Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Symbol
ATRA
Shares outstanding
9,606,000 shares
Disclosed Ownership
950,994 shares
Ownership
9.9%
Form type
SCHEDULE 13D/A
Filing time
14 May 2026, 21:00:18 UTC
Date of event
12 May 2026

Quoteable Key Fact

"Redmile Group, LLC disclosed 9.9% ownership in Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA) on 12 May 2026."

Quick Takeaways

  • Redmile Group, LLC filed SCHEDULE 13D/A for Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA).
  • Disclosed ownership: 9.9%.
  • Date of event: 12 May 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 May 2026, 21:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 950,994 0 950,994 /s/ Jeremy C. Green Managing Member 0001425738
Jeremy C. Green 9.9% 950,994 0 950,994 /s/ Jeremy C. Green Jeremy C. Green 0001650527
Redmile Biopharma Investments II, L.P. 6.9% 651,924 0 651,924 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments II (GP), LLC, general partner of Redmile Biopharma Investments II, L.P. 0001772230
Redmile Strategic Long Only Trading Sub, Ltd. 6.1% 576,148 0 576,148 /s/ Jeremy C. Green Managing Member of Redmile Group, LLC, investment manager of Redmile Strategic Long Only Trading Sub, Ltd. 0002048243
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .